🇺🇸 Rabipur in United States

33 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Reaction — 5 reports (15.15%)
  2. Paraesthesia — 4 reports (12.12%)
  3. Flushing — 3 reports (9.09%)
  4. Generalised Erythema — 3 reports (9.09%)
  5. Headache — 3 reports (9.09%)
  6. Inappropriate Schedule Of Drug Administration — 3 reports (9.09%)
  7. Pruritus Generalised — 3 reports (9.09%)
  8. Rash — 3 reports (9.09%)
  9. Swollen Tongue — 3 reports (9.09%)
  10. Urticaria — 3 reports (9.09%)

Source database →

Rabipur in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Rabipur approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Rabipur in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.